CytoGPT™ Platform:
Developed in collaboration with NVIDIA, this platform utilizes AI to:
- Auto-generate optimized protocols
- Perform in-depth process analysis
- Expand CMC knowledge base
Developed in collaboration with NVIDIA, this platform utilizes AI to:
With BioEngineAI, you can leverage the most advanced assay technology to conduct precise analytics and gain an in-depth understanding of your cell and gene therapies. An AI-driven engine capable of recognizing and analyzing cell images and videos, enhancing process understanding and control.
CRISPR screens, assay data, FC, IMC, imaging
RNAseq, WGS, methylation, ATACseq
Viability and growth assays, stability tests, pH, DO
Mechanisms, pathways, components, function, pathophysiology
Scientific, patent, regulatory
For scalable and reliable manufacturing by robust integration of experimentation and modeling